Practical issues in the management of the patient with small cell lung cancer.
Small cell lung cancer (SCLC) accounts for 20% of all lung cancers. More than two thirds of patients with SCLC present with clinically evident distant metastases. Patients with limited stage disease are treated with a combination of chemotherapy and chest radiation. Patients with extensive stage disease and good performance status are candidates for combination chemotherapy. Almost all patients relapse after an initial response. This article focuses on the common sense approach to the management of SCLC.
Govindan
R
R
Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Ihde
D C
DC
D000465:Algorithms; D018288:Carcinoma, Small Cell / Q000175:diagnosis* / Q000628:therapy*; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D003663:Decision Trees; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis